Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist

Saved in:
Bibliographic Details
Published in:Alzheimer's & Dementia: Translational Research & Clinical Interventions
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301676783763456
collection WordPress RSS
FRELIP Feed Integration
container_title Alzheimer's & Dementia: Translational Research & Clinical Interventions
description
discipline_display Gerontology and Geriatrics
discipline_facet Gerontology and Geriatrics
format Online Article
RSS Article
genre Journal Article
id rss_article:69997
institution FRELIP
journal_source_facet Alzheimer's & Dementia: Translational Research & Clinical Interventions
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
Gerontology and Geriatrics
General
Gerontology and Geriatrics
sub_discipline_display General
sub_discipline_facet General
subject_display Gerontology and Geriatrics
General
Gerontology and Geriatrics
Gerontology and Geriatrics
General
Gerontology and Geriatrics
subject_facet Gerontology and Geriatrics
General
Gerontology and Geriatrics
title Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_auth Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_full Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_fullStr Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_full_unstemmed Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_short Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
title_sort population pharmacokinetics of remlifanserin (acp‐204), a serotonin 2a receptor inverse agonist
topic Gerontology and Geriatrics
General
Gerontology and Geriatrics
url https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70254?af=R